I have now finished 5 1/2 months as a writer at Suite101.com. I have a little bit of perspective, though not really enough yet to know if it is worthwhile. As I've stated before, I first applied to Suite in the hopes of using it to increase my platform--that is, increase the number of potential book buyers I would bring to a publisher. For that purpose, how much money I earn there should be irrelevant. Of course, I couldn't let it be irrelevant forever, so money has become one of the goals and motivating factors for participation there.
For platform-building purposes, the number of page views I get is most important. The first graph (wish I could get the graphs clearer--click on the graph for a clearer image) shows where I stand with page views. I peaked in mid-October when I had 53 articles posted, and began a slow decline. Page views tanked over Thanksgiving, though that's to be expected. They have recovered nicely, but not to where they were right before Thanksgiving. Still, my current readership is 86,000 people per year with current article total at 70. That's not too shabby.
Revenue is going up, though I'm way below the reported site average. The second graph shows my revenue history. It is more volatile than are page views, but the trend is upward. The third graph shows revenue per week. While revenue is still low, I had four of my best weeks in November to early December. As I wrote once before, I began writing some different type articles around October 21st to try to stimulate revenue. That seems to have worked, though the coincident peak in page views at the same time is curious, if not causal. I'll have to watch that and see how page views go in January, after we get past all this holiday hubbub.
Last week the site went through a major face lift, completely changing its look. The site had limited functionality for about 20 hours, which probably hurt page views and revenue. It's too soon to know if and how the new look will affect readership and revenue. I can and do hope for the best, however.
No comments:
Post a Comment